Omega-3-acid Ethyl Esters (Lovaza) For Severe Hypertriglyceridemia
Year: 2008
Type: article
Abstract: Hypertriglyceridemia is an independent risk factor for coronary heart disease (CHD), according to the guidelines from the Third Report of the National Cholesterol Education Program Expert Panel on the Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (NCEP ATP III).1 High triglyceride (TG) levels are frequently found in combination with insulin resistance, obesity, and low levels of high-density lipoprotein-cholesterol (HDL-C) in patients with the metabolic syndrome. Extremely high TG concentrations can cause a number of medical problems, including CHD and acute pancreatitis.
The primary causes of hypertrigly-ceridemia include cigarette smoking, very-high-carbohydrate diets, disease (i.e., diabetes, nephrotic syndrome), certain drugs (i.e., corticosteroids, protease inhibitors), and genetic factors. Excess acute alcohol intake can also raise TG levels, especially when alcohol is consumed with food.1,2
TG levels are classified as follows: normal (below 150 mg/dL), borderline–high (150–199 mg/dL), high (200–499 mg/ dL), or very high (500 mg/dL or more).1
Approximately five to six million people in the U.S. have TG levels exceeding 500 mg/dL. NCEP ATP III guidelines endorse pharmacological treatment of hypertriglyceridemia above this value. The underlying principles in treating very high TG levels are to prevent acute pancreatitis and CHD. Standard treatments include: 1
diet and exercise
smoking and alcohol cessation
medications:
niacin (e.g., Niaspan, Kos)
fibric acids: gemfibrozil (Lopid, Pfizer); fenofibrate (TriCor, Abbott)
HMG–CoA reductase inhibitors (statins)
fish oil
For more than 30 years, it was recognized that certain ethnic populations, such as the Native Alaskans, had much lower mortality rates from cardiovascular disease (CVD). Further examination revealed that their diets were high in polyunsaturated fatty acids.3,4 Small observational and large epidemiological studies have since confirmed that ingesting omega-3 fatty acids (a type of long-chain polyunsaturated fatty acid) was associated with a reduced rate of premature deaths from CVD.5,6
Omega-3 and omega-6 fatty acids are essential, because humans do not synthesize them. The omega-6 fatty acids include linolenic acid, gamma-linolenic acid, and arachidonic acid. The three main types of omega-3 fatty acids are alpha-linolenic acid (ALA), eicosapenta-enoic acid (EPA), and docosahexaenoic acid (DHA) (Figure 1).
Open in a separate window
Figure 1
Chemical structures of omega-3 fatty acids. (From www.wikipedia.com.7)
Source: PubMed Central
Author: Renee R. Koski
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Keywords: omega-3 acid ethyl esters, severe hypertriglyceridemia, triglyceride-lowering therapy, acute pancreatitis prevention, coronary heart disease risk, omega-3 fatty acids, fish oil, polyunsaturated fatty acids, metabolic syndrome, nicotinic acid, statins, NCEP ATP III guidelines, cardiovascular mortality, Alaska Natives
Open Access status: green
OpenAlex ID: W2155017092
